Abstract:Sulfated polymannuronate (SPMG), a novel anti-AIDS drug candidate, combats HIV-1 infection mainly by binding to gp120 protein with high affinity. To explore the structural basis of this anti-HIV-1 action, size-defined oligosaccharides were prepared by semi-synthesis or separated from native SPMG. In this study, a series of homogeneously sized SPMG fragments are evaluated for their capacity to bind rgp120 using surface plasmon resonance (SPR) analysis. The minimum SPMG fragment size that interacts with rgp120 is a hexasaccharide. Additionally, binding capacity increases with the molecular size of oligosaccharides, with the affinity of large fragments (> or = 15-16 saccharides) approaching that of full-sized SPMG. Competitive inhibition and stoichiometric analyses disclose that SPMG oligos bind to multiple binding sites on gp120. Sugar chains longer than 15-16 saccharide residues (SPMG) display multivalent interactions, with one sugar chain binding to two or three gp120 molecules. Consistent with binding data, a positive correlation exists between the size of SPMG oligosaccharides and their anti-HIV activity. The octasaccharide is established to be the minimal active fragment inhibiting syncytium formation and lowering the P24 core antigen level in HIV-IIIB-infected CEM cells. Alternatively, about 50% anti-HIV activity was observed for 15-16 saccharides, whereas a 19-20-saccharide fragment displayed anti-HIV activity equivalent to native SPMG. The structures of the unique minimum hexasaccharide specifically recognized by gp120 and the minimum octasaccharide combating HIV-IIIB infection were representatively structured as [ManA (2s)beta1-4 ManA(2s/3s)]n.

The potential molecular targets of marine sulfated polymannuroguluronate interfering with HIV-1 entry. Interaction between SPMG and HIV-1 rgp120 and CD4 molecule.

The potential molecular targets of marine sulfated polymannuroguluronate interfering with HIV-1 entry

Multiple and Multivalent Interactions of Novel Anti-Aids Drug Candidates, Sulfated Polymannuronate (Spmg)-Derived Oligosaccharides, with Gp120 and Their Anti-Hiv Activities.

Sulfated Polymannuroguluronate Inhibits Tat-induced SLK Cell Adhesion Via a Novel Binding Site, a KKR Spatial Triad

The Glycan‐mediated Mechanism on the Interactions of Gp120 with CD4 and Antibody: Insights from Molecular Dynamics Simulation

Potentiation of T Cell Function by a Marine Algae-Derived Sulfated Polymannuroguluronate: in Vitro Analysis of Novel Mechanisms.

Studies of Marine Sulfated Polymannuroguluronate on Endothelial Cell Proliferation and Endothelial Immunity and Related Mechanisms

SPR Sensor-Based Analysis of the Inhibition of Marine Sulfated Glycans on Interactions Between Monkeypox Virus Proteins and Glycosaminoglycans

T-Cell Receptor (tcr)/cd3 is Involved in Sulfated Polymannuroguluronate (Spmg)-Induced T Lymphocyte Activation

The Molecular Mechanism of Two Coreceptor Binding Site Antibodies X5 and 17b Neutralizing HIV-1: Insights from molecular dynamics simulation.

Sulfated polymannuroguluronate (SPMG), a novel anti-acquired immune deficiency syndrome (AIDS) drug candidate, inhibits T cell apoptosis via combating oxidative damage of mitochondria

Expression of recombinant plasmid of HIV-1 gp120 and IFN-gamma in E. coli and its immunoregulatory effect]

Sulfated Polymannuroguluronate, A Novel Anti-Aids Drug Candidate, Inhibits T Cell Apoptosis By Combating Oxidative Damage Of Mitochondria

Dextran sulfate and heparin interact with CD4 molecules to inhibit the binding of coat protein (gp120) of HIV.

Small-molecule Inhibitors of HIV-1 Entry Block Receptor-Induced Conformational Changes in the Viral Envelope Glycoproteins.

Discovery of Small Molecular Inhibitors Targeting Hiv-1 Gp120-Cd4 Interaction Drived from Bms-378806

Theoretical Studies on the Interactions and Interferences of HIV-1 Glycoprotein Gp120 and Its Coreceptor CCR5

Salivary Agglutinin Inhibits HIV Type 1 Infectivity Through Interaction with Viral Glycoprotein 120.

The investigations on HIV-1 gp120 bound with BMS-488043 by using docking and molecular dynamics simulations

Synthetic glycopolypeptides as potential inhibitory agents for dendritic cells and HIV-1 trafficking.

Small-molecule HIV-1 gp120 inhibitors to prevent HIV-1 entry: an emerging opportunity for drug development